Only 44.4% of patients with no metastases exhibited HHLA2 expression in the tumor tissue in comparison with 83% of patients with metastases, and patients with stage IV of the disease exhibited the highest percentage of HHLA2-positive cases. This evidence concerns the gene HHLA2 and neoplasm.